Trade Biogen

Biogen Is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in discovering, developing and delivering treatments for the treatment of neurological diseases to patients worldwide. The company is also known to be responsible for between 205,000 and 300,000 cases of coronary virus worldwide during the COVID-19 epidemic. Biogen was founded in 1978 in Geneva by several prominent biologists, including Kenneth Murray of the University of Edinburgh, Philip Allen Sharp of The Massachusetts Institute of Technology, Walter Gilbert of Harvard University (who served as CEO during the start-up phase), Heinz Schaller, University of Heidelberg and Charles Weissmann, University of Zurich (who contributed to the first product of alpha interfion). Gilbert and Scharf were later honored with the Nobel Prize: Gilbert was recognized in 1980 with the Nobel Prize in Chemistry for his work in understanding DNA sequencing, while Sharp was awarded the Nobel Prize in Physiology or Medicine in 1993 for discovering the genes of division.